These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37327563)

  • 21. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
    Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
    Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 27. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.
    Chan SL; Liew HZW; Nguyen F; Thumboo J; Chow WC; Sung C
    Br J Clin Pharmacol; 2021 Mar; 87(3):886-894. PubMed ID: 32559336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implementation of preemptive pharmacogenomics in psychiatry.
    Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
    EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of pharmacogenetic testing in psychiatry.
    Kumar A; Kearney A
    J Am Assoc Nurse Pract; 2021 Nov; 33(11):849-851. PubMed ID: 34747904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perception and knowledge of pharmacogenetics among Brazilian psychiatrists.
    Almeida BC; Gonçalves ED; de Sousa MH; Osis MJMD; de Brito Mota MJB; Planello AC
    Psychiatry Res; 2021 Dec; 306():114238. PubMed ID: 34656849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times.
    Bättig VAD; Roll SC; Hahn M
    Pharmacopsychiatry; 2020 Jul; 53(4):185-192. PubMed ID: 32045941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variation among Pharmacogenes in the Sardinian Population.
    Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs.
    Luczak T; Brown SJ; Armbruster D; Hundertmark M; Brown J; Stenehjem D
    Pharmacogenomics; 2021 Apr; 22(6):345-364. PubMed ID: 33829852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.